Conversation with Univ. of Minnesota researcher using First Responders in nation-wide trial of hydroxychloroquine.

Sarah Lofgren is part of a team of researchers conducting a trial of hydroxychloroquine. Working out of the University of Minnesota, the team is providing the drug to First Responders to assess the impact in preventing the onset of COVID-19 as well as the drug’s ability to mitigate the more severe symptoms of the disease.

Among the topics of discussion are:

The impact of anecdotal evidence of hydroxychloroquine’s
useage around the world.

Does a pandemic offer an excuse to relax drug approval protocols?

Why use First Responders in a hydroxychloroquine trial?

Can therapies like hydroxychloroquine provide enough breathing space
to get America back to work?

Listen to “Conversation with Univ. of Minnesota researcher using First Responders in nation-wide trial of hydroxychloroquine.” on Spreaker.